. Erratum: Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. J Clin Oncol 2024 Sep 13:JCO2401883. doi: 10.1200/JCO-24-01883.
PMID: 39270141